Editorial: A Challenge for the College
As we prepare to enter the third millenium, what will be the face and the scope of our medical profession? We can be sure that it will not be the same. But just how different it will be is currently an enigma. In this editorial, I focus upon two aspects of relevance and importance to the clinical discipline which is embraced by the American College of Medical Quality, rather than try to predict which particular nuance of financial reform will be used ' to achieve the goal of &dquo;access for all&dquo;. The first is population-based medicine and the second is accountability. What is their relevance to members of the American College of Medical Quality in this time of reform?
Population-based medicine is a part of preventive medicine, but it is not the exclusive province of that discipline. Accountability as a term is gradually entering the realm of clinical practice and is a term that has different meanings to different groups of physicians. Clinical quality management, the discipline of the American College of Medical Quality, bridges both population-based medicine and patient-based medicine and is involved with accountability. At the one-dimensional level of structure, process and outcome, the term accountability may be interchangeable with quality assurance, but the meaning of accountability goes further. By taking in patient well-being, satisfaction and outcome, a second dimension is added-the science of outcomes management. Third and fourth dimensions fill out this paradigm-the natural history of the condition and time (1) .
The relationship between population and patient-based medicine is present but is subtle. Figuratively, if one is attempting to achieve a specific medical outcome, one may obtain that outcome by concentrating on the structure and process. However one can also achieve that outcome by identifying a population at risk and reducing that risk. Alternatively, one may achieve the same outcome by removing the threat to health. The outcome, therefore, links the three processes (which I call accountability) at the micro, mini, and macro levels. Conventionally we have called these processes, quality assurance, preventive medicine, and public health.
Looking at the spectrum from population-based medicine to patient-based medicine, the Preventive Medicine Council of the American Medical Association has been discussing the relationships, in general, between all the nonclinical disciplines and the clinical ones. The Council's chairman, Dr. Weisbuch, has set forth a model reflecting that spectrum (2) . A slight modification of the Weisbuch model (2) suggests the following: 9 Some practitioners function at the micro level; the diabetologist is concerned with the effect of insulin at a cellular level. The virologist works to understand the effect of viruses on certain cells. 9 At the next level, the mini level, are those practitioners who deal with an organ system, or multiple organ systems (the cardiologist and the opthalmologist, for example), or the whole patient (the internist or family practitioner). o The macro level practitioner deals with problems in terms of communities and populations. Examples of these practitioners are the preventive medicine physicians, and physicians in administrative services, insurance medicine, and our specialty of clinical quality management.
In actual practice, the separation between the micro and mini levels is not as precise or clear-cut as the examples given; nor is the separation between the mini and macro levels. As an example, the infectious disease physician may work not only as a virologist, but also as an internist, even though the primary focus is on the causative agent. Likewise, the family practitioner, to address a patient's presenting problem, must often consult and work with other family members before a satisfactory, long-term outcome can be achieved.
To this spectrum of clinical practice from the molecular or cellular level to organ-specific medicine and on to population-based medicine, we can attach some predicted outcomes. We might consider that the outcome for treatment at a cellular or molecular level is the response to specific agents such as insulin or antiviral agents. The measurement for operational success for an opthalmologist performing cataract surgery is self-evident. Likewise, a public health physician faced with a problem concerning a local water contaminant has a specific treatment strategy. In fact, one can make up a matrix of type of medical practice (micro, mini, or macro) and outcome (response to treatment, outcomes management, and population outcome), and place both clinical and nonclinical disciplines in their appropriate boxes.
At this point, I would like to re-emphasize the role in population-based medicine of two disciplines, both recognized by being seated at the American Medical Association House of Delegates, namely, insurance medicine and clinical quality management. The first is organized as the American Academy of Insurance Medicine (AAIM), and the second is our own organization, ACMQ. Both organizations have been sorely underestimated in their roles in both patient-based (clinical) medicine and population-based medicine. A prime core skill which the former possesses, is the science of morbidity and mortality methodologies. This is a fundamental base for the life insurance industry and it is only now that the patient-based medicine disciplines are coming to understand that it is essentially the same as outcomes measurement. ACMQ on the other hand, with an emphasis on quality and continuous quality improvement and, therefore, upon outcome, should take as a challenge, the role of bringing population-based medicine specialists and particularly those in the insurance-based discipline into a more collaborative and productive relationship with the patient-based disciplines.
In summary, there are challenges for those of us who are currently not perceived to be in a typical patient-based discipline, to demonstrate our role in the spectrum of medicine in an era of health system reform. 
